Anxiety , Depression in Patients Receiving Chemotherapy for Solid Tumors (original) (raw)
Related papers
A study to assess the level of anxiety among cancer patient under chemotherapy
International Journal of Advanced Psychiatric Nursing
Anxiety is an emotion characterized by an exaggerated reaction to a certain situation. Many illnesses can cause anxiety. Cancer is a group of diseases involving the abnormal growth of cells with the ability to invade or spread to other parts of the body. These tumors are contrasted with benign, non-spreading tumors. Treatment methods, including chemotherapy, can increase anxiety in cancer survivors. This study aims to assess the anxiety level of cancer patients undergoing chemotherapy. Objectives To assess knowledge of level of anxiety among cancer patients To find out the significant association between socio-demographic variables and level of anxiety among cancer patients. Methods: Descriptive research design was used to assess the knowledge of level of anxiety patients in Saveetha Medical College and Hospital. The total number 50 study participants were participated who met all inclusion criteria. Purposive sampling technique used. Data collected by administering standardized questionnaire. The data oraganized and analysed by using descriptive and inferential statistics. Results: Among the 50 cancer patients (n=50) approached, 31(62%) were aged above 55 years, 38(76%) were male, 26(52%) were Hindus, 31(62%) had primary education, 44(88%) were married, 31(62%) had other occupation, 33(66%) belonged nuclear family and 28(56%) had family income of <10000. The result shows that 26(52%) had minimal to moderate anxiety 11(22%) were normal, 8(16%) had marked to severe anxiety and 5(10%) had most extreme anxiety. The mean score of anxiety among cancer patients under chemotherapy was 54.78 with standard deviation 9.88 With minimum score of 41.0 and maximum score of 78.0.
International Journal of Research in Medical Sciences
Background: A cancer diagnosis can have a significant impact on mental health and wellbeing. Cancer is the second most common cause of death after heart diseases and it accounted for 9.6 million deaths worldwide in 2018. Various individual psychosocial and contextual factors potentially contribute to the development of anxiety and depression among people with cancer. In comparison with general people, the prevalence of anxiety and depression is frequently found to be higher among cancer patient, but estimates vary due to various factors, such as the type of cancer, treatment setting, and prognosis of disease. The present study was conducted to find out the estimate of depression in cancer patients undergoing chemotherapy and determine the various factors associated with depression.Methods: A cross-sectional study was conducted amongst cancer patients undergoing chemotherapy at Department of Oncology, Government Bundelkhand Medical College and Hospital, Sagar from January to April 20...
TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH, 2016
Background: Potentially every aspect of life in cancer patients is found to be accompanied by a mental illness of anxiety and depression that affects the Physical relationships, Psychological wellbeing, Social relationships and the Environmental domain thereby reducing the QOL of cancer patients significantly. The advancements in cancer treatment have led to marked improvement in the survival rates of cancer patients; however, distressing symptoms of anxiety and depression arising due to treatment modalities are yet to be endured. The proposed study is considered valuable since it emphasized on the quality of life of cancer patients during their treatment for cancer symptoms as one of the possible outcomes. Because patients are the best source of information for QOL data, therefore inpatients for chemotherapy treatment and outpatients for radiotherapy treatment were recruited in the study to obtain a unique perspective on how QOL is defined, assessed, and perceived with respect to anxiety and depression during the treatment sessions. Objectives: The present study was conducted to assess the association and correlation of Anxiety and Depression with the domains of Quality of Life of cancer patients during inpatient Chemotherapy sessions or outpatient Radiotherapy sessions. The primary objective was to analyze the anxiety and depression levels (Recognition patterns) with their impact on QOL of cancer patients during chemotherapy or radiotherapy sessions. Methods: It was a Psychological intervention, non-experimental, cross-sectional, descriptive, observational, hospital-based evaluation study. The Research study was conducted at Medical and Radiation Oncology department of Dr. B.L. Kapur Memorial Hospital, New Delhi, India with total duration of 5 months (December 2015-April 2016). A convenient sample of 60 patients undergoing cancer treatment was selected in which 30 cancer patients were on chemotherapy (CT Group) and the other 30 cancer patients were on radiotherapy (RT Group). Data collection was performed by using 3 validated Psychological interventional tools: WHOQOL-Bref Questionnaire, Zung Self-Rating Anxiety scale (ZSAS) and Zung Self-Rating Depression scale (ZSDS). Appropriate statistical tests by using SPSS v.17 software were utilized to determine the significant association of anxiety and depression with QOL domains. Results: As a result, it was observed that 21(35%) males [6(20%) in Chemotherapy group and 15(50%) in Radiotherapy group] and 39(65%) females [24(80%) in Chemotherapy group and 15(50%) in Radiotherapy group] participated in the research study. Majority of the patients 32(53.34%) were found to be in the age range of 46-60 years. Out of the enrolled subjects, 33(55%) were undergoing Breast cancer treatment, 6(10%) were undergoing Head cancer treatment, and 21(35%) were undergoing Neck cancer treatment. Anxiety affected the Physical domain (p=0.007), and Environmental domain (p=0.036) in the Chemotherapy group; and Social domain (p=0.016) in the Radiotherapy group. On the other hand, Depression affected the Social domain (p=0.043) in Chemotherapy group; and Social domain (p=0.012) in the Radiotherapy group. Values of p < 0.05 were considered to be statistically significant. Conclusion: It is evident from the research study that Cancer patients on chemotherapy were more badly affected in some domains of Quality of life due to anxiety and depression as compared to the patients on radiotherapy treatment regimen. Moreover, it was observed that with the increase in Anxiety and Depression symptomatic levels, there was a marked decline in respective domains of the
Objective: Cancer is one among the life threatening diseases in present days it has biological, psychological and sociological impact on individual’s life. People living with this deadly disease have numerous psychological abnormalities like stress, depression and anxiety. The present study aimed to investigate the levels of anxiety and depression among cancer and non cancer patients. Methods:80 patients were randomly selected among them 40 were cancer patients and 40 were non cancerpatients. The Sinha’s Anxiety scale and Depression scale constructed by Karim & Tiwari was used to measure the anxiety and Depression among patients. For statistical analysis independent sample t-Test was applied. Findings: The results show significant differences between the mean scores of cancer and non cancer patients in respect to anxiety and depression. Conclusion: On the basis of our results we may concluded that cancer patients have higher levels of anxiety and depression than non cancerous patients.
2009
BACKGROUND: Distress is considered by many, the sixth vital sign in cancer care. Researches refer to high incidence of distress in cancer population. Levels of emotional distress should be evaluated in appropriate intervals as other vital signs are. Neglecting distress levels may lead losses in the therapeutic and preventive plan, with implications in adherence and coping with treatment. This procedure is standard in several countries, but not in Brazil. METHOD: In view of such reality, the present study objective was evaluate the incidence of distress, anxiety and depression during chemotherapy, among 169 patients, with age between 17 and 86 years (median553), with 18 different diagnoses of cancer, being those of major incidence: Oncohematologic (26%); Breast cancer (22.5%); Gastrointestinal (17.7%). This research was authorized by the ethics committee. The procedures of gathering data included the consent of the patients and in application of the Distress Thermometer (DT) and the Hospital Anxiety and Depression Scale (HAD). The data were analyzed according to criteria defined in literature and with help of the software SPSS 15.0. RESULTS: During the treatment 32.4% of patients were diagnosed with distress, 25.3% with anxiety and 25% with depression. While evaluating distress incidence in the diagnostics of greater incidence it was verified that: 1) Oncohematologic: 31.2% of patients showed distress, 23.2% with anxiety and 22.6% with depression; 2) Breast cancer: 26.7% of patients with distress, 23.8% with anxiety and 23.1% with depression; 3) Gastrointestinal: 28.4% of patients with distress, 25.1% with anxiety and 24.3 with depression. CONCLUSIONS: The high incidence of distress showed the necessity of an effective management of the emotional consequences of the diagnostic and treatment of cancer. Establishing a routine of screening for psychological distress and intervention, one may increase the possibility of bringing about a preventive evaluation of symptoms and psychological and psychiatric disturbances. The small difference showed between the main diagnostics in this study, assume that the distress, anxiety and depression are related to the impact of the diagnostic and the consequences of the treatment as a whole. RESEARCH IMPLICATIONS: The present study suggests that the prevalence of this suffering is independent of the type of cancer diagnosis. This research implicates the need of a deeper study of both variables (type of cancer and distress, anxiety and depression), and also an analysis of possible correlations with others variables. CLINICAL IMPLICATIONS: The screening for psychological distress may provide a preventive actuation in the reduction or elimination of psychiatric and psychologic disorders. These procedures subside action of intervention and prevention in relation to cancer patients and contribute to justify the adoption of evaluation measure of distress in oncologic treatment units. ACKNOWLEDGEMENT OF FUNDING: None.
Background: Depression and anxiety are psychological and physiological disturbances persisting in cancer patients with high prevalence worldwide, particularly in low-and middle-income countries, due to complexities of determinants of health including biological, individual, socio-cultural, and treatment-related characteristics. Although depression and anxiety have an enormous impact on adherence, length of stay at the hospital, quality of life, and treatment outcomes, studies on psychiatric disorders remain limited. Thus, this study determined the prevalence and factors of depression and anxiety among patients with cancer in Rwanda. Methods: A cross-sectional study was conducted among patients with cancer from the Butaro Cancer Center of Excellence. We administered socio-demographic questionnaires and psychometric instruments. Bivariate logistic regressions were computed to identify significant factors to be exported into the multivariate logistic models. Then, odds ratios and their % confidence intervals were applied, and statistical significance at p <. were considered to confirm significant associations. Results: The prevalence of depression and anxiety was. and. %, respectively. Patients with cancer initiated to chemotherapy had a greater likelihood of being depressed [AOR =. ; % CI (.-.)] than those initiated to chemotherapy and counseling. Breast cancer was significantly associated with a greater risk of depression [AOR =. , % CI (.-.)] than Hodgikins's Lymphoma cancer. Furthermore, patients with depression had greater odds of developing anxiety [AOR =. , % CI (.-.)] than those with no depression. Those su ering from depression were almost two times more likely to experience anxiety [AOR =. ; % CI (.-.)] than their counterparts. Conclusion: Our results revealed that depressive and anxious symptomatology is a health threat in clinical settings that requires enhancement of clinical monitoring and prioritization of mental health in cancer health facilities. Designing biopsychosocial interventions to address associated factors needs special attention to promote the health and wellbeing of patients with cancer.
Psychiatry journal, 2016
Background. The biomedical care for cancer has not been complemented by psychosocial progressions in cancer care. Objectives. To find the prevalence of anxiety and depression amongst cancer patients in a hospital setting. Design and Setting. This cross-sectional study was conducted at the tertiary care hospitals Shifa International Hospital Islamabad and Nuclear Medicine, Oncology, and Radiotherapy Institute [NORI]. Patients and Methods. 300 patients were interviewed from both the outpatient and inpatient department using The Aga Khan University Anxiety and Depression Scale (AKUADS). Main Outcome Measures. Using a score of 20 and above on the AKUADS, 146 (48.7%) patients were suffering from anxiety and depression. Results. When cross tabulation was done between different factors and the cancer patients with anxiety and depression, the following factors were found out to be significant with associated p value < 0.05: education of the patient, presence of cancer in the family, the ...
Assessment Of The Anxiety, Depression And Coping Strategies In Diagnosed Cancer Patients
Asian Journal of Health Sciences, 2013
Across the world, there are people who suffer from different types of cancers. These patients suffer problems of anxiety and depression as the commonest psychological problems. Therefore, an exploratory study was conducted to assess the anxiety, depression and coping strategies in diagnosed cancer patients in selected hospital of Indore. Samples of 50 patients both males and females were taken for the study using non-probability purposive sampling technique. Assessment of data was done using standardized tools i.e. Hamilton's anxiety scale, Beck's Depression inventory and a set of 5 open ended questionnaire for the patients. Statistical findings revealed that there was no association between the level of anxiety and the socio demographic variables. The findings of the study revealed that majority of the cancer patients suffer from symptoms of anxiety (23 out of 50 patients, 46%) and depression (19 out of 50 patients, 38%) in their daily life. To adapt to these stressful cond...